Search

everythinglearnresearchcommunity

for

Search:↓

PCOS is a common hormonal disorder in women, treated with lifestyle changes and medications like hormonal contraceptives and metformin.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Women with PCOS have fewer activated T cells in their ovarian follicles, which might affect fertility.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Beta-catenin is crucial for skin cell growth, development, and cancer formation.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Finasteride may help treat chronic CSC, improving vision.

About 13% of women had idiopathic hirsutism and 8.5% had polycystic ovary syndrome in a group of Iranian women.

The protein StAR is found in 17 different organs and can affect hair loss and brain functions, but its full role is not yet fully understood.

Hormonal treatments are effective for severe or persistent acne and should be used with other acne therapies, considering potential side effects.

Ketoconazole reduced hair growth and improved acne in women, but caused side effects needing careful monitoring.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Women with polycystic ovary syndrome tend to have a longer distance between the clitoris and anus.

The enzyme that changes testosterone to a stronger form is mostly found in the part of the hair follicle called the dermal papilla.

About 8.5% of women in Salvador, Brazil, have Polycystic Ovary Syndrome.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Finasteride treatment in male rats causes long-lasting effects on depression-like behavior, brain cell growth, inflammation, and gut bacteria composition.

Hirsutism is excessive male-pattern hair growth in women, often caused by hormonal imbalances, and requires ongoing treatment to manage.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

Continuous light exposure in rats leads to PCOS-like symptoms and suggests sleep habits might affect the disorder's development.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.

Women with PCOS have unhealthy changes in their cholesterol particles that are not related to their body weight.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.